Karen Doucette

4.0k total citations
86 papers, 2.1k citations indexed

About

Karen Doucette is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Karen Doucette has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 40 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Karen Doucette's work include Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (26 papers) and Liver Disease Diagnosis and Treatment (18 papers). Karen Doucette is often cited by papers focused on Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (26 papers) and Liver Disease Diagnosis and Treatment (18 papers). Karen Doucette collaborates with scholars based in Canada, United States and Belgium. Karen Doucette's co-authors include J. A. Fishman, Louise C. Ivers, David C. Kendrick, Jutta K. Preiksaitis, Joshua Levitsky, Atul Humar, Deepali Kumar, Oriol Manuel, Xiaoli Pang and Helen S. Te and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Karen Doucette

81 papers receiving 2.0k citations

Peers

Countries citing papers authored by Karen Doucette

Since Specialization

Citations

This map shows the geographic impact of Karen Doucette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Doucette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Doucette more than expected).

Fields of papers citing papers by Karen Doucette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Doucette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Doucette. The network helps show where Karen Doucette may publish in the future.

Co-authorship network of co-authors of Karen Doucette

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Doucette. A scholar is included among the top collaborators of Karen Doucette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Doucette. Karen Doucette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network 2025 ·Transplant Infectious Disease ·Sara Belga, (unknown), Stephen Lee, Christine M. Durand, Karen Doucette	0
2	Sexual and gender minoritized persons in organ and tissue donation: a qualitative analysis 2025 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·Murdoch Leeies, (unknown), David Collister, Emily Christie, Karen Doucette, (unknown), (unknown), (unknown), (unknown), (unknown), Matthew J. Weiss, Sonny Dhanani, Julie Ho	0
3	Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival? 2024 ·Transplant Infectious Disease ·(unknown), (unknown), Mark L. Robbins, Dima Kabbani, Karen Doucette, Carlos Cervera	1
4	Increased Infectious Risk Donor Status and Equity‐Relevant Predictors of Organ Donation Organization Approach and Caregiver Consent for Deceased Organ Donation in a Canadian Province (2015–2021) 2024 ·Clinical Transplantation ·Murdoch Leeies, Karen Doucette, Brenden Dufault, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dawei Xie, Emily Christie, David Collister, Matthew J. Weiss, Sonny Dhanani, Julie Ho	0
5	Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta 2024 ·American Journal of Transplantation ·Dima Kabbani, Efrat Orenbuch‐Harroch, (unknown), Sarah Broad, (unknown), Sara Belga, (unknown), Emily Christie, (unknown), Soroush Shojai, Sita Gourishankar, Carlos Cervera, Karen Doucette	3
6	The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis 2024 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), (unknown), Sandy Campbell, Karen Doucette, (unknown), Juan G. Abraldeṣ, Carlos Cervera, Dima Kabbani	13
7	Sexual and gender minority relevant policies in Canadian and United States organ and tissue donation and transplantation systems: An opportunity to improve equity and safety 2023 ·American Journal of Transplantation ·Murdoch Leeies, David Collister, Emily Christie, Karen Doucette, (unknown), (unknown), (unknown), Julie Ho	4
8	Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial 2023 ·The Lancet Infectious Diseases ·(unknown), Holly Hoang, Maryna Yaskina, Dima Kabbani, Karen Doucette, Stephanie Smith, Cecilia Lau, (unknown), (unknown), (unknown), (unknown), (unknown), Carlos Cervera	11
9	Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada 2023 ·Journal of Hepatology ·(unknown), Sabrina S. Plitt, Karen Doucette, Carla S. Coffin, (unknown), Joan Robinson, Carmen Charlton	5
10	Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada 2022 ·JHEP Reports ·Carla Osiowy, (unknown), Sarah Haylock‐Jacobs, (unknown), Scott Fung, David Wong, Gerald Y. Minuk, Karen Doucette, Philip Wong, Edward Tam, Curtis Cooper, Alnoor Ramji, Mang Ma, (unknown), Keith Tsoi, Carla S. Coffin	16
11	Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial 2022 ·PLoS ONE ·(unknown), Holly Hoang, Maryna Yaskina, Dima Kabbani, Karen Doucette, Stephanie Smith, Cecilia Lau, (unknown), (unknown), (unknown), Carlos Cervera	3
12	Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study 2021 ·Journal of Viral Hepatitis ·Mina Farag, Scott Fung, Edward Tam, Karen Doucette, Alexander Wong, Alnoor Ramji, Brian Conway, Curtis Cooper, Keith Tsoi, Philip Wong, Giada Sebastiani, Mayur Brahmania, Sarah Haylock‐Jacobs, Carla S. Coffin, Bettina E. Hansen, Harry L.A. Janssen	18
13	Distinct Hepatitis B and HIV co‐infected populations in Canada 2020 ·Journal of Viral Hepatitis ·Curtis Cooper, (unknown), David Wong, Sarah Haylock‐Jacobs, Abdel Aziz Shaheen, Carla Osiowy, Scott Fung, Karen Doucette, Alexander Wong, Lisa Barrett, Brian Conway, Alnoor Ramji, Gerald Y. Minuk, Giada Sebastiani, Philip Wong, Carla S. Coffin	1
14	Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later? 2018 ·American Journal of Transplantation ·B. Kiberd, Karen Doucette, Amanda J. Vinson, Karthik Tennankore	11
15	Granulocyte colony‐stimulating factor for hepatitis C therapy‐associated neutropenia: systematic review and economic evaluation 2011 ·Journal of Viral Hepatitis ·Puneeta Tandon, Karen Doucette, Konrad Fassbender, Ben Vandermeer, Tamara Durec, D. M. Dryden	12
16	Prospective Monitoring of BK Polyomavirus Infection Early Posttransplantation in Nonrenal Solid Organ Transplant Recipients 2008 ·Transplantation ·Karen Doucette, Xiaoli Pang, (unknown), (unknown), Michelle Carbonneau, Sandra M. Cockfield, Jutta K. Preiksaitis	42
17	Gene Expression of Porcine Lymphotrophic Herpesvirus-1 in Miniature Swine with Posttransplant Lymphoproliferative Disorder 2007 ·Transplantation ·Karen Doucette, Frank J. M. F. Dor, Robert A. Wilkinson, Stanley I. Martin, Christene A. Huang, David K. C. Cooper, David H. Sachs, Jay A. Fishman	22
18	Efficacy of Antiretroviral Therapy Programs in Resource‐Poor Settings: A Meta‐analysis of the Published Literature 2005 ·Clinical Infectious Diseases ·Louise C. Ivers, David C. Kendrick, Karen Doucette	251
19	Posttransplant Lymphoproliferative Disease After Allogeneic Transplantation of the Spleen in Miniature Swine 2004 ·Transplantation ·Frank J. M. F. Dor, Karen Doucette, Nicolas J. Mueller, Robert A. Wilkinson, (unknown), Isabel M. McMorrow, Yau‐Lin Tseng, Kenji Kuwaki, Stuart L. Houser, Jay A. Fishman, David K. C. Cooper, Christene A. Huang	20
20	Oseltamivir: a clinical and pharmacological perspective 2001 ·Expert Opinion on Pharmacotherapy ·Fred Y. Aoki, Karen Doucette	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact